Literature DB >> 26457022

Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Vikas Gupta1, Xian-Jun Mah1, Maria Carmela Garcia1, Christina Antonypillai1, David van der Poorten1.   

Abstract

Rates of non-alcoholic fatty liver disease (NAFLD) are increasing worldwide in tandem with the metabolic syndrome, with the progressive form of disease, non-alcoholic steatohepatitis (NASH) likely to become the most common cause of end stage liver disease in the not too distant future. Lifestyle modification and weight loss remain the main focus of management in NAFLD and NASH, however, there has been growing interest in the benefit of specific foods and dietary components on disease progression, with some foods showing protective properties. This article provides an overview of the foods that show the most promise and their potential benefits in NAFLD/NASH, specifically; oily fish/ fish oil, coffee, nuts, tea, red wine, avocado and olive oil. Furthermore, it summarises results from animal and human trials and highlights potential areas for future research.

Entities:  

Keywords:  Coffee; Diet; Fish; Fish oils; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Nuts; Olive oil; Red wine; Tea; Walnuts

Mesh:

Substances:

Year:  2015        PMID: 26457022      PMCID: PMC4588084          DOI: 10.3748/wjg.v21.i37.10621

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  133 in total

Review 1.  Overview of epidemiological studies on wine, health and mortality.

Authors:  J C Ruf
Journal:  Drugs Exp Clin Res       Date:  2003

2.  Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

Review 3.  Medicinal benefits of green tea: Part I. Review of noncancer health benefits.

Authors:  Raymond Cooper; D James Morré; Dorothy M Morré
Journal:  J Altern Complement Med       Date:  2005-06       Impact factor: 2.579

4.  Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.

Authors:  Valerio Nobili; Giorgio Bedogni; Anna Alisi; Andrea Pietrobattista; Patrizia Risé; Claudio Galli; Carlo Agostoni
Journal:  Arch Dis Child       Date:  2011-01-12       Impact factor: 3.791

5.  Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.

Authors:  Neal D Freedman; Teresa M Curto; Karen L Lindsay; Elizabeth C Wright; Rashmi Sinha; James E Everhart
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

Review 6.  Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids.

Authors:  Dimitrios G Bouzianas; Stella D Bouziana; Apostolos I Hatzitolios
Journal:  Nutr Rev       Date:  2013-10-22       Impact factor: 7.110

7.  Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.

Authors:  Lutgarda Bozzetto; Anna Prinster; Giovanni Annuzzi; Lucia Costagliola; Anna Mangione; Alessandra Vitelli; Raffaella Mazzarella; Margaret Longobardo; Marcello Mancini; Carlo Vigorito; Gabriele Riccardi; Angela A Rivellese
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

8.  Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: the PREDIMED study.

Authors:  Núria Ibarrola-Jurado; Mònica Bulló; Marta Guasch-Ferré; Emilio Ros; Miguel A Martínez-González; Dolores Corella; Miquel Fiol; Julia Wärnberg; Ramón Estruch; Pilar Román; Fernando Arós; Ernest Vinyoles; Lluis Serra-Majem; Xavier Pintó; María-Isabel Covas; Josep Basora; Jordi Salas-Salvadó
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Avocado consumption is associated with better diet quality and nutrient intake, and lower metabolic syndrome risk in US adults: results from the National Health and Nutrition Examination Survey (NHANES) 2001-2008.

Authors:  Victor L Fulgoni; Mark Dreher; Adrienne J Davenport
Journal:  Nutr J       Date:  2013-01-02       Impact factor: 3.271

Review 10.  Polyunsaturated Fatty acids in children.

Authors:  Ji-Hyuk Lee
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-09-30
View more
  10 in total

Review 1.  Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.

Authors:  Pankaj Prasun; Ilona Ginevic; Kimihiko Oishi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

Review 2.  Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Tannaz Eslamparast; Puneeta Tandon; Maitreyi Raman
Journal:  Nutrients       Date:  2017-07-26       Impact factor: 5.717

Review 3.  Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Manuel Suárez; Noemí Boqué; Josep M Del Bas; Jordi Mayneris-Perxachs; Lluís Arola; Antoni Caimari
Journal:  Nutrients       Date:  2017-09-22       Impact factor: 5.717

4.  Pistachio Consumption Prevents and Improves Lipid Dysmetabolism by Reducing the Lipid Metabolizing Gene Expression in Diet-Induced Obese Mice.

Authors:  Simona Terzo; Gaetano Felice Caldara; Vincenzo Ferrantelli; Roberto Puleio; Giovanni Cassata; Flavia Mulè; Antonella Amato
Journal:  Nutrients       Date:  2018-12-01       Impact factor: 5.717

5.  Effects of oily fish and its fatty acid intake on non-alcoholic fatty liver disease development among South Korean adults.

Authors:  Li-Juan Tan; Sangah Shin
Journal:  Front Nutr       Date:  2022-07-22

6.  Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.

Authors:  Sofía Montemayor; Catalina M Mascaró; Lucía Ugarriza; Miguel Casares; Isabel Llompart; Itziar Abete; María Ángeles Zulet; J Alfredo Martínez; Josep A Tur; Cristina Bouzas
Journal:  Nutrients       Date:  2022-08-03       Impact factor: 6.706

7.  Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research.

Authors:  Tong-Shuo Zhang; Hua-Lei Qin; Tong Wang; Hai-Tao Li; Hai Li; Shi-Hai Xia; Xiao-Hui Xiang
Journal:  World J Hepatol       Date:  2016-11-28

Review 8.  Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.

Authors:  Brandon J Perumpail; Andrew A Li; Umair Iqbal; Sandy Sallam; Neha D Shah; Waiyee Kwong; George Cholankeril; Donghee Kim; Aijaz Ahmed
Journal:  Diseases       Date:  2018-09-10

9.  Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stage.

Authors:  Fereshteh Pashayee-Khamene; Mahdi Saber-Firoozi; Behzad Hatami; Bahram Rashidkhani; Vahideh Aghamohammadi; Elahe Mohammadi; Azita Hekmatdoost
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

Review 10.  Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity's Metabolic Consequences.

Authors:  Melina Konstantinidi; Antonios E Koutelidakis
Journal:  Medicines (Basel)       Date:  2019-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.